Form 8-K - Current report:
SEC Accession No. 0001157523-12-004461
Filing Date
2012-08-10
Accepted
2012-08-10 08:00:24
Documents
2
Period of Report
2012-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CELLDEX THERAPEUTICS, INC. 8K a50372421.htm 8-K 17279
2 EXHIBIT 99.1 a50372421ex99-1.htm EX-99.1 72026
  Complete submission text file 0001157523-12-004461.txt   90602
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 121022563
SIC: 2835 In Vitro & In Vivo Diagnostic Substances